ストックスクリーナーアプリを入手
35.59
2.33%
0.81
アフターアワーズ：
35.59
前日終値:
$34.78
開ける：
$34.56
24時間の取引高:
1.07M
Relative Volume:
0.93
時価総額：
$2.65B
収益：
-
当期純損益:
$-301.06M
株価収益率:
-7.308
EPS:
-4.87
ネットキャッシュフロー:
$-248.01M
1週間 パフォーマンス:
-7.08%
1か月 パフォーマンス:
-4.94%
6か月 パフォーマンス:
-1.69%
1年 パフォーマンス:
+11.32%
1日の値動き範囲:
$34.56
$35.94
1週間の範囲:
$34.35
$38.83
52週間の値動き範囲:
$28.21
$53.92
Springworks Therapeutics Inc Stock (SWTX) Company Profile
名前
Springworks Therapeutics Inc
セクター
電話
203-883-9490
住所
100 WASHINGTON BOULEVARD, STAMFORD, CT
SWTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SWTX
Springworks Therapeutics Inc
|
35.59 | 2.65B | 0 | -301.06M | -248.01M | -4.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-20 | 開始されました | Evercore ISI | Outperform |
| 2024-02-05 | 開始されました | Guggenheim | Buy |
| 2022-12-01 | 開始されました | BofA Securities | Buy |
| 2021-01-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-29 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-05-05 | 開始されました | Barclays | Overweight |
| 2020-03-19 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-03-04 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-01-21 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-12-04 | 開始されました | H.C. Wainwright | Buy |
| 2019-10-08 | 開始されました | Cowen | Outperform |
| 2019-10-08 | 開始されました | Goldman | Buy |
| 2019-10-08 | 開始されました | JP Morgan | Overweight |
| 2019-10-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Springworks Therapeutics Inc (SWTX) 最新ニュース
Barclays PLC Purchases 58,645 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Comprehensive Market Analysis of Latest Published 9 Rare Genetic Disorders Reports | DelveInsight - GlobeNewswire Inc.
(SWTX) On The My Stocks Page - Stock Traders Daily
Comparing Titan Pharmaceuticals (NASDAQ:TTNP) & SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
Kuehn Law Encourages Investors of SpringWorks, Therapeutics Inc. to Contact Law Firm - GuruFocus.com
Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison's Top 2 Picks - Seeking Alpha
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress By Investing.com - Investing.com South Africa
SpringWorks Therapeutics' SWOT analysis: stock potential amid clinical progress - Investing.com India
Lord Abbett & CO. LLC Has $34.27 Million Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $3.20 Million Stock Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (SWTX) Up 14.5% Since Last Earnings Report: Can It Continue? - MSN
Main Management ETF Advisors LLC Buys Shares of 23,280 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Charles Schwab Investment Management Inc. Raises Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Trading Report - Stock Traders Daily
Soros Fund Management LLC Acquires 174,321 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Insider Sell Alert: Badreddin Edris Sells 20,000 Shares of Sprin - GuruFocus.com
Springworks Therapeutics COO sells $839,335 in stock By Investing.com - Investing.com UK
Erste Asset Management GmbH Takes Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock - Investing.com
Springworks Therapeutics CEO Islam Saqib sells $2 million in stock By Investing.com - Investing.com Nigeria
Saqib Islam Sells 49,000 Shares of SpringWorks Therapeutics Inc (SWTX) - GuruFocus.com
High Growth Tech Stocks to Watch in December 2024 - Simply Wall St
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by The Manufacturers Life Insurance Company - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by HighVista Strategies LLC - MarketBeat
Walleye Capital LLC Boosts Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Fmr LLC Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Intech Investment Management LLC Invests $676,000 in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Dynamic Technology Lab Private Ltd Buys Shares of 13,717 SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
Ally Bridge Group NY LLC Invests $7.30 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference - The Manila Times
SpringWorks Therapeutics to Present at Evercore ISI HealthCONx Conference | SWTX Stock News - StockTitan
Massachusetts Financial Services Co. MA Boosts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
(SWTX) Investment Analysis - Stock Traders Daily
SpringWorks Therapeutics' SWOT analysis: stock shows promise amid challenges - Investing.com
Alpha DNA Investment Management LLC Makes New $411,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
GSA Capital Partners LLP Makes New $209,000 Investment in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World
Eagle Asset Management Inc. Sells 54,366 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat
SpringWorks Therapeutics (NASDAQ:SWTX) Trading 8.1% HigherShould You Buy? - MarketBeat
SpringWorks Therapeutics Inc. (SWTX): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Insider Monkey
Evercore ISI Begins Coverage on SpringWorks Therapeutics (NASDAQ:SWTX) - Defense World
SpringWorks started at outperform by Evercore ahead of FDA decision - MSN
Does SpringWorks Therapeutics (SWTX) Have the Potential to Rally 92.68% as Wall Street Analysts Expect? - MSN
SpringWorks' Q3 Loss Narrower Than Expected, Revenues Miss Mark - MSN
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Boosted by Victory Capital Management Inc. - MarketBeat
SpringWorks Therapeutics: Q3 Earnings Snapshot - AOL
Equities Analysts Set Expectations for SWTX FY2024 Earnings - Defense World
Wedbush Has Negative Forecast for SWTX FY2024 Earnings - Defense World
When (SWTX) Moves Investors should Listen - Stock Traders Daily
Analyst Estimates: Here's What Brokers Think Of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Report - Yahoo Finance
Here's What Analysts Are Forecasting For SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) After Its Third-Quarter Results - Simply Wall St
Springworks Therapeutics Inc (SWTX) 財務データ
収益
当期純利益
現金流量
EPS
Springworks Therapeutics Inc (SWTX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Islam Saqib | Chief Executive Officer |
Dec 02 '24 |
Sale |
41.37 |
49,000 |
2,027,357 |
1,014,368 |
| Islam Saqib | Chief Executive Officer |
Sep 03 '24 |
Sale |
40.57 |
49,000 |
1,988,033 |
1,063,368 |
| Edris Badreddin | Chief Operating Officer |
Sep 03 '24 |
Sale |
40.65 |
20,000 |
812,954 |
229,600 |
2.88%
2.65%
大文字化:
|
ボリューム (24 時間):